Alnylam Pharmaceuticals | Kontanter Og Tilsvarende



Cash And Equivalent Endring Dato
Acadia Pharmaceuticals USD 755.99M 190.66M 2024-12
Agios Pharmaceuticals USD 76.25M 177.48M 2024-12
Alnylam Pharmaceuticals USD 966.43M 133.49M 2024-12
Amgen USD 11.97B 2.96B 2024-12
Arrowhead Research USD 51.79M 47.4M 2024-12
BioMarin Pharmaceutical USD 613.22M 324.54M 2024-12
Incyte USD 1.69B 383.72M 2024-12
Ionis Pharmaceuticals USD 242.08M 92.53M 2024-12
Moderna USD 1.93B 283M 2024-12
Neurocrine Biosciences USD 233M 116.1M 2024-12
Novartis USD 11.46B 2.15B 2024-12
PTC Therapeutics USD 779.71M 253.71M 2024-12
Regeneron Pharmaceuticals USD 17.91B 15.9B 2024-12
Sanofi 6.8B 1.92B 2024-06
Sarepta Therapeutics USD 1.1B 905.16M 2024-12
Takeda JPY 494.13B 364.89B 2024-12
Tectonic Therapeutic USD 159.1M 26.03M 2024-09
Ultragenyx Pharmaceutical USD 173.73M 23.11M 2024-12
Vertex Pharmaceuticals USD 4.57B 669.6M 2024-12
Xencor USD 40.88M 11.84M 2024-12



Alnylam Pharmaceuticals Kontanter Og Tilsvarende - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Mar 2025.